PRESS RELEASE published on 09/24/2024 at 07:45, 1 year 11 months ago Marinomed Biotech AG reports positive clinical results for unique Carragelose eye drops Marinomed Biotech AG reports positive clinical results for Carragelose eye drops, improving dry eye symptoms by 54%. The eye drops are well tolerated and hold valid Medical Device Directive certificate Marinomed Biotech AG Carragelose Clinical Results Dry Eye Eye Drops
BRIEF published on 09/18/2024 at 17:26, 2 years ago Marinomed Biotech AG Announces Capital Increase Excluding Subscription Rights Investors Capital Increase Marinomed Biotech AG Subscription Rights Issue Price
BRIEF published on 09/18/2024 at 17:26, 2 years ago Marinomed Biotech AG annonce une augmentation de capital hors droits de souscription Augmentation De Capital Investisseurs Marinomed Biotech AG Droits De Souscription Prix D'émission
PRESS RELEASE published on 09/18/2024 at 17:21, 2 years ago EQS-Adhoc: Marinomed Biotech AG resolves capital increase excluding statutory subscription rights by issuing 154,053 no-par value bearer shares at an issue price of EUR 5 per share Marinomed Biotech AG resolves capital increase by issuing 154,053 bearer shares at EUR 5 per share, excluding statutory subscription rights Capital Increase Marinomed Biotech AG Subscription Rights Bearer Shares EUR 5
BRIEF published on 09/15/2024 at 17:54, 2 years ago Marinomed Biotech AG Sets Price Range for Capital Increases Capital Increase Restructuring Share Price Investor Negotiations Marinomed Biotech
BRIEF published on 09/15/2024 at 17:54, 2 years ago Marinomed Biotech AG fixe une fourchette de prix pour ses augmentations de capital Augmentation De Capital Restructuration Cours De L'action Biotechnologie Marinomed Négociations Avec Les Investisseurs
PRESS RELEASE published on 09/15/2024 at 17:49, 2 years ago EQS-Adhoc: Marinomed Biotech AG sets price range for potential 10% capital increase and potential second capital increase, in each case excluding statutory subscription rights Marinomed Biotech AG sets price range for potential 10% capital increase and second capital increase, excluding statutory subscription rights Capital Increase Marinomed Biotech AG Price Range Authorized Capital 2024 Restructuring Proceedings
BRIEF published on 09/11/2024 at 07:50, 2 years ago Marinomed Biotech AG: First Carragelose Products Receive New Medical Device Regulation (MDR) Certification Regulatory Compliance Medical Devices Carragelose MDR Certification Marinomed
BRIEF published on 09/11/2024 at 07:50, 2 years ago Marinomed Biotech AG : les premiers produits à base de carraghénane reçoivent la nouvelle certification du Règlement sur les dispositifs médicaux (MDR) Dispositifs Médicaux Conformité Réglementaire Certification MDR Marinomé Carraghénose
PRESS RELEASE published on 09/11/2024 at 07:45, 2 years ago Marinomed Biotech AG: First Carragelose products receive new Medical Device Regulation (MDR) certification Marinomed Biotech AG's first Carragelose products receive new Medical Device Regulation (MDR) certification, enhancing safety and value for the portfolio Regulatory Compliance Medical Devices Marinomed Biotech AG MDR Certification Carragelose Products
Published on 09/22/2026 at 00:00, 6 hours 32 minutes ago Alset AI Announces Shares for Debt Transaction
Published on 09/21/2026 at 15:45, 14 hours 47 minutes ago Datavault AI and Cutting-Edge Sports Management Announce Dream Bowl XV at AT&T Stadium and Launch First-of-Its-Kind Bowl Combine
Published on 09/21/2026 at 14:20, 16 hours 12 minutes ago Doctor's Choice(R) Clinically-Proven Scrubs Launching on Amazon Canada
Published on 09/21/2026 at 14:05, 16 hours 27 minutes ago Winners of this Year's Semmelweis-Richter International Journalism Award Announced
Published on 09/21/2026 at 14:00, 16 hours 32 minutes ago Dateline Files Motion to Resume Operations at Colosseum
Published on 09/22/2026 at 06:15, 17 minutes ago Smart Manufacturing, Shared Opportunities: 2026 World Manufacturing Convention Opens Sept. 20 in Hefei
Published on 09/22/2026 at 05:50, 42 minutes ago 2026 China-Europe Talent Forum Held in Beijing, Collectively Opening a New Chapter in Innovation Cooperation
Published on 09/22/2026 at 01:05, 5 hours 27 minutes ago ESENTIA Announces the Execution of an Agreement to Acquire the Guadalajara-Manzanillo Natural Gas Pipeline System, Connecting Existing System to the Port of Manzanillo
Published on 09/21/2026 at 22:05, 8 hours 27 minutes ago Abivax Presents Business Updates and First Half 2026 Financial Results
Published on 09/21/2026 at 22:05, 8 hours 27 minutes ago Abivax présente les dernières avancées de ses activités et ses résultats financiers du premier semestre 2026
Published on 09/21/2026 at 18:19, 12 hours 13 minutes ago Déclaration de rachats d'actions effectués par la Compagnie de Saint-Gobain du 14 au 18 septembre 2026
Published on 09/21/2026 at 18:19, 12 hours 13 minutes ago Reporting on share buyback transactions carried out between September 14 and September 18, 2026
Published on 09/21/2026 at 18:01, 12 hours 30 minutes ago Partnership agreement signed between Manitou Group and HD Construction Equipment
Published on 09/21/2026 at 17:46, 12 hours 46 minutes ago WEB SA - STATUTORY HALF-YEAR RESULTS AS OF 30/06/2026
Published on 09/21/2026 at 17:46, 12 hours 46 minutes ago WEB SA - RESULTATS SEMESTRIELS STATUTAIRES AU 30/06/2026